Download Speaker Presentations

 

 

 

DAY 1: MONDAY, JUNE 21, 2017

line

“THE MSL WORKSHOP DAY”

An Overview of the Evolution of the MSL Role from the Global Perspective
Samuel Dyer, CEO and Chairman, THE MSL SOCIETY

The Challenges of MSL Onboarding
Chin Siew Loh, Senior Manager, Medical Affairs, MUNDIPHARMA

MSLs in Launch Preparations
Helena Zhang, Chief Medical Officer, QUINTILESIMS
Kaweng Mah, Regional Medical Excellence Lead, AMGEN
Li Xie, TA Head of GI, TAKEDA

Defining MSL Excellence & Establishing MSL Support Programs
Chin Siew Loh, Senior Manager, Medical Affairs, MUNDIPHARMA
Ingrid Wang, Senior Medical Liaison Development Manager, SANOFI

Understanding and Engaging Your KOLs
Viola Wan, Associate MSL Excellence Director, TAKEDA

 

DAY 2: THURSDAY, JUNE 22, 2017

line

The 5 Critical Questions of Medical Affairs Across Lifecycle Management
Xinhai Qiu, Medical Director, ABBVIE

The Evolving Role of Medical Affairs in China
Fangning Zhang, Partner, MCKINSEY & COMPANY

“Across the Lifecycle”: Involving Medical Affairs from Drug Discovery & Preclinical to Post-Marketing & Life Cycle Management
Moderator:
Fangning Zhang, Partner, MCKINSEY & COMPANY

“Internal Partnerships” Town Hall Session
Moderator:
Victoria Elegant, VP, Region Head Medical, AMGEN

What Types of Clinical Trials Are Initiated by the Medical Affairs Department?
Moderator:
Sean Su, Senior Director of Business Development, Greater China, QUINTILESIMS
Speakers:
Xiling Zhang, Medical Director, KUNTUO
Na Guo, Principal Epidemiologist, GSK R&D CHINA
Jiguang Wang, Director of Clinical Trials & Epidemic Disease Research Center, Director of Hypertension Research Institute, RUIJIN HOSPITAL

Statistics for Non-Statisticians: Design and Analysis of Interventional Clinical Trials & Non-Interventional Studies
Tong Guo, Head of Biostatistics, South Africa & Asia, QUINTILESIMS
Jianing Di, Director, China Site Head, Statistics & Decision Sciences, JANSSEN R&D

 

DAY 3: JUNE 23, 2017

line

Prevent, Intercept & Cure: Imagine That!
Jijo James, Chief Medical Officer, Medical Devices, JOHNSON & JOHNSON

How Do We Leverage Digital Technologies to Engage KOLs/HCPs More Effectively and Efficiently?
Moderator:
Dannis Chang, Strategic Program Lead- Business Innovations and Strategy, GENENTECH
Speakers:
Shan He, CBO, LINKDOC
Dayong Li, COO, MEDBANKS
Jim Lu, CEO, PURPLE CLINIC
Yusheng Zhang, CEO, XINGSHULIN

Biosimilars: Is Medical Affairs Support Needed or Not?
Stephen Doyle, VP of Specialty Care Business Unit, BOEHRINGER-INGELHEIM
Frank Fan, Consultant on Pharmaceutical Medicine


Copyright © 2012 Lychee Group LLC. All rights reserved.